These inhibitors work by binding to the ATP-binding site of Aurora kinases, thereby preventing their phosphorylation activity. This blockade disrupts the normal functions of the kinases, such as spindle assembly and chromosome segregation, leading to cell cycle arrest and apoptosis. This mechanism is particularly useful in targeting rapidly dividing cancer cells.